Advertisement

Topics

Companies Related to "Adenosine Receptor Antagonist Pipeline Insight 2018 Report Updated" [Most Relevant Company Matches] - Page: 3 RSS

15:27 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Adenosine Receptor Antagonist Pipeline Insight 2018 Report Updated" found in our extensive corporate database of over 50,000 company records.

Showing "Adenosine Receptor Antagonist Pipeline Insight 2018 Report Updated" Companies 51–75 of 1,700+

Relevant

Insight Genetics, Inc.

Insight Genetics is dedicated to improving the lives of cancer patients through advanced molecular diagnostics that enable precision in cancer care. The company specializes in the discovery, development and commercialization of companion diagnostics that detect specific cancer biomarkers and assist in guiding the effective diagnosis and treatment of cancer...


Insight Pharmaceuticals

Headquartered in Langhorne, PA, Insight Pharmaceuticals was founded in 1997 as a manufacturer and marketer of niche consumer over-the-counter medications that aid users in managing common ailments. The company's philosophy to provide effective medications that offer maximum relief for a variety of symptoms has led to the acquisition of such notable brands as Sucrets® Sore Throat and Cough Lozenge...

Pharmacopeia Drug Discovery

Pharmacopeia is committed to discovering and developing novel therapeutics to address significant medical needs. The Company has a broad portfolio advancing toward clinical validation, both independently and with partners. Pharmacopeia's most advanced internal program is a dual-acting angiotensin and endothelin receptor antagonist (DARA) for hypertension and diabetic kidney disease for which Phase...


Medscape, LLC

Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.Most specialty sites are organized consistently so you'll know where to find your favorite features as you move from specialty to specialty. Ea...

Arlington Medical Resources

AMR's Hospital Anti-Infectives Insight Series: Gram-Negative Infections analyzes hospital antifungal prescribing patterns using AMR's comprehensive and highly detailed clinical data in conjunction with primary research and extensive understanding of emerging therapies and forecasts. This report contains U.S. data and examines the reasons behind physicians' product preferences, factors driving hosp...

Sleep Number Corporation

The leader in sleep innovation, Sleep Number delivers proven, quality sleep through effortless, adjustable comfort and biometric sleep tracking. Sleep Number’s revolutionary 360® smart bed and proprietary SleepIQ® technology platform are proving the connection between sleep and well-being. With one of the most comprehensive databases of biometri...

Bio Balance Incorporated

BIO BALANCE INC., a New York corporation, founded in 1993, is engaged in studies of biomedical problems. The Company applies its experience in computational chemistry, molecular modeling, pharmacology and biochemistry to such specific areas of specialization as: Specific Formulations to Prevent Receptor Desensitization Molecular Modeling Construction of 3-Dimensional (3D) Models of Proteins Comput...

BTI

BTI has been manufacturing growth factor (GF) and attachment factor (AF) products since 1981. Our extensive product line includes receptor-grade, aseptically packaged GFs and AFs. These are highly purified proteins that have been membrane filtered, aseptically filled and lyophilized. Most BTI GFs have been tested in cell culture, receptor binding studies and in immunoassays. Some GFs are availa...

Santaris Pharma A/S

Santaris Pharma is a science-based product-driven biopharmaceutical company focused on oncology. Our mission is to discover, develop and commercialise new and better drugs drugs for the treatment of cancer.We seek to fulfil this mission through an integrated business strategy comprising:Rapid development of own products based on our pioneering RNA antagonist drug platformStructuring of corporate p...

Five Prime Therapeutics

Five Prime Therapeutics, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,600 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets f...

Tokai Pharmaceuticals Inc.

Tokai Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative therapies for prostate cancer and other hormonally driven diseases. The company’s lead drug candidate, galeterone, is a highly selective, multi-targeted oral small molecule being developed for the treatment of patients with metastatic castratio...

Biotech Sage

BioTech Sage Report is newsletter that is published monthly. Our report provides quality investment research and information for uncovering the best ideas in stocks and investment strategies. While our email updates focuses on news events, scientific advancements or biotechnology opportunities. Our goal is to provide valuable information to assist you in your investment strategies. The aim of BioT...

Lundbeck Research USA, Inc.

Now that scientists have mapped the human genome, new opportunities exist for developing drugs that exclusively target specific receptors associated with the symptoms and causes of a disease.Receptor-specific drugs provide a new model in drug discovery that can improve the state-of-the-art treatment for many serious and common disorders. Lundbeck Research USA uses this discovery model to pursue n...

Triumvira Immunologics, Inc.

Triumvira Immunologics, Inc. (“Triumvira”) is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., with the vision of developing novel T cell therapies that are safer and more efficacious than current gene therapy cancer treatments, including chimeric antigen receptor (CAR) and engineered T ...

POXEL S.A.

Poxel uses its development expertise in metabolism to advance a pipeline of drug candidates focused on the treatment of metabolic disorders, including type 2 diabetes and non-alcoholic steatohepatitis (NASH). We have successfully completed the Phase 2 clinical program for our first-in-class lead product, Imeglimin, which targets mitochondrial dysfunction, ...

Medtech Insight

Medtech Insight, a division of Windhover Information, Inc., provides business information and intelligence on new trends, technologies, and companies in the medical device, diagnostics, and biotech marketplace. We offer a broad range of products and services for medical technology executives, including:The Medtech Insight Newsletter Medical Technology Investment & Partnering Conferences Market & ...

Aragon Pharmaceuticals Inc.

Aragon Pharmaceuticals is a privately held small-molecule drug discovery company identifying breakthrough medicines for the treatment of hormonally driven cancers. These cancers are traditionally treated with anti-hormonal therapies but often become resistant, and follow-on therapies are largely ineffective. The company plans to initiate a clinical trial with its lead compound, ARN-509, in patient...

Corcept Therapeutics

Corcept Therapeutics Incorporated is a pharmaceutical company engaged in the development of drugs for the treatment of severe psychiatric and neurological diseases. Our lead product, CORLUX, is currently in three Phase 3 clinical trials for the treatment of the psychotic features of psychotic major depression (PMD), a disorder that affects approximately three million adults in the United States ea...

Biomonitoring Info

What: An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC). For information o...

Triumvira Immunologics Inc.

Triumvira Immunologics, Inc. is an immunotherapy company co-founded in 2015 by Dr. Jonathan Bramson at McMaster University and Bloom Burton & Co., a niche life-sciences investment bank, with the vision of developing novel T cell therapies that are safer and more efficacious than current cell therapy cancer treatments, including chimeric antigen receptor (C...

ChartWise Medical Systems, Inc.

ChartWise Medical Systems, Inc., based in Wakefield, RI, is a medical software company and a leading provider of web-based Clinical Documentation Improvement solutions. ChartWise solutions assist physicians and clinical documentation specialists with increased efficiencies and completeness of documentation, queries and workflow. Developed by Jon Elion, M.D...

BioTech Stock Report

Each month the Wong's BioTech Stock Report provides a fresh, intuitive, inside look at the science and business of biotech investing. Our report takes you behind the canned quotes from press releases, beyond the momentum-driven stock analysts, and past the hype of mainstream stock-touters. The BioTech Stock Report gets to the core of what makes biotechnology companies tick: Science and Innovation....

OSI Pharmaceuticals

OSI Pharmaceuticals is committed to “shaping medicine and changing lives” by developing and commercializing high-quality and novel pharmaceutical products that extend life or improve the quality of life for patients with cancer, diabetes, and obesity. We specialize in the discovery and development of innovative molecular targeted therapies that address significant unmet medical needs, and st...

3D Printing 2018

Unum Therapeutics Inc.

Unum Therapeutics uses its proprietary Antibody-Coupled T cell Receptor (ACTR) technology in combination with tumor-targeting antibodies, which is designed to activate the body’s own immune system to fight cancer. Unum is actively building a pipeline of ACTR programs in which proprietary, tumor-targeting antibodies are armed to improve their therapeut...


More From BioPortfolio on "Adenosine Receptor Antagonist Pipeline Insight 2018 Report Updated"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks